PI-RADS version 2: What you need to know

Clinical Radiology

Volumn 70, Issue 11, 2015, Pages 1165-1176

  Barrett, T ^a   Turkbey, B ^b   Choyke, P L ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CHRONIC PROSTATITIS; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DIGITAL RECTAL EXAMINATION; DYNAMIC CONTRAST ENHANCED; FAMILY HISTORY; GLEASON SCORE; HUMAN; INFORMATION PROCESSING; LIKERT SCALE; MALE; MEDICAL HISTORY; NOMOGRAM; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE IMAGING REPORTING AND DATA SYSTEM; REVIEW; SCORING SYSTEM; SEMINAL VESICLE DISEASE; SIGNAL NOISE RATIO; T2 WEIGHTED IMAGING; TUMOR BIOPSY; TUMOR VOLUME; CANCER STAGING; METHODOLOGY; PATHOLOGY; PROCEDURES; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY; STANDARDS;

HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PROSTATIC NEOPLASMS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY;

EID: 84942991464     PISSN: 00099260     EISSN: 1365229X     Source Type: Journal    
DOI: 10.1016/j.crad.2015.06.093     Document Type: Review

References (50)

1. J. Maddams, M. Utley, and H. Møller Projections of cancer prevalence in the United Kingdom, 2010-2040 Br J Cancer 107 2012 1195 1202
2. M.A. Levine, M. Ittman, J. Melamed, and et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer J Urol 159 1998 471 475
3. R. Kvåle, B. Møller, R. Wahlqvist, and et al. Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study BJU Int 103 2009 1647 1654
4. P.A. Pinto, P.H. Chung, A.R. Rastinehad, and et al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging J Urol 186 2011 1281 1285
5. C.M. Moore, N.L. Robertson, N. Arsanious, and et al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review Eur Urol 63 2013 125 140
6. National Institute for Health and Care Excellence Prostate cancer: diagnosis and treatment. Clinical guideline 175 (Update of clinical guideline 58) 2014 Available at: http://www.nice.org.uk/guidance/cg175/evidence/cg175-prostate-cancer-full-guideline3 [accessed 14.04.15]
7. H.U. Ahmed, A. Kirkham, M. Arya, and et al. Is it time to consider a role for MRI before prostate biopsy? Nat Rev Clin Oncol 6 2009 197 206
8. National Prostate Cancer Audit First Year Annual Report - Organisation of Services and Analysis of Existing Clinical Data 2014 The Royal College of Surgeons of England London Available at: http://www.npca.org.uk/wp-content/uploads/2014/11/NPCA-Annual-Report-FINAL-10-11-14.pdf [accessed 14.04.15]
9. G. Gaziev, K. Wadhwa, T. Barrett, and et al. Defining the learning curve for multi-parametric MRI of the prostate using MRI-TRUS fusion guided transperineal prostate biopsies as a validation tool BJU Int 2014 Aug 7 10.1111/bju.12892 [Epub ahead of print]
10. O. Akin, C.C. Riedl, N.M. Ishill, and et al. Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer Eur Radiol 20 2010 995 1002
11. A.P. Kirkham, P. Haslam, J.Y. Keanie, and et al. Prostate MRI: who, when, and how? Report from a UK consensus meeting Clin Radiol 68 2013 1016 1023
12. J.O. Barentsz, J. Richenberg, R. Clements, and et al. ESUR prostate MR guidelines 2012 Eur Radiol 22 2012 746 757
13. ACR, ESUR, and AdMeTech Foundation Prostate Imaging and Reporting and Data System: Version 2 2014 Available at: 14/4/2015 http://www.acr.org/∼/media/ACR/Documents/PDF/QualitySafety/Resources/PIRADS/PIRADS%20V2.pdf [accessed 14.04.15]
14. M.M. Siddiqui, S. Rais-Bahrami, B. Turkbey, and et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer JAMA 313 2015 390 397
15. B. Turkbey, H. Mani, O. Aras, and et al. Prostate cancer: can multiparametric MR imaging help identify patients who are candidates for active surveillance? Radiology 268 2013 144 152
16. S.R. Bott, H.U. Ahmed, R.G. Hindley, and et al. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer BJU Int 106 2010 1607 1611
17. T. Barrett, H.A. Vargas, O. Akin, and et al. Value of the hemorrhage exclusion sign on T1-weighted prostate MR images for the detection of prostate cancer Radiology 263 2012 751 757
18. B. Turkbey, M.J. Merino, E.C. Gallardo, and et al. Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology J Magn Reson Imaging 39 2014 1443 1448
19. D. Le Bihan, E. Breton, D. Lallemand, and et al. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging Radiology 168 1988 497 505
20. E.M. Lawrence, S.Y. Tang, T. Barrett, and et al. Prostate cancer: performance characteristics of combined T W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion Eur Radiol 24 2014 1497 1505
21. R. Renard-Penna, P. Mozer, F. Cornud, and et al. Prostate Imaging Reporting And Data System and Likert scoring system: multiparametric MR imaging validation study to screen patients for initial biopsy Radiology 275 2015 458 468
22. T. Vaché, F. Bratan, F. Mège-Lechevallier, and et al. Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy Radiology 272 2014 446 455
23. R. Renard-Penna, P. Mozer, F. Cornud, and et al. Prostate Imaging Reporting and Data System and Likert scoring system: multiparametric MR imaging validation study to screen patients for initial biopsy Radiology 275 2015 458 468
24. T.H. Kuru, M.C. Roethke, P. Rieker, and et al. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate BJU Int 112 2013 1080 1087
25. B.G. Muller, J.H. Shih, S. Sankineni, and et al. Inter-observer agreement and accuracy of the revised Prostate Imaging - Reporting and Data System (PI-RADS) for interpreting multiparametric MRI of the prostate Radiology 2015 Jun 18 142818 [Epub ahead of print]
26. A.B. Rosenkrantz, and S.S. Taneja Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI AJR Am J Roentgenol 202 2014 109 120
27. O. Akin, E. Sala, C.S. Moskowitz, and et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging Radiology 239 2006 784 792
28. A. Oto, A. Kayhan, Y. Jiang, and et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging Radiology 257 2010 715 723
29. G. Thörmer, J. Otto, M. Reiss-Zimmermann, and et al. Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values Eur Radiol 22 2012 1820 1828
30. G.J. Litjens, T. Hambrock, C. Hulsbergen-van de Kaa, and et al. Interpatient variation in normal peripheral zone apparent diffusion coefficient: effect on the prediction of prostate cancer aggressiveness Radiology 265 2012 260 266
31. M. Sasaki, K. Yamada, Y. Watanabe, and et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study Radiology 249 2008 624 630
32. J. Iwazawa, T. Mitani, S. Sassa, and et al. Prostate cancer detection with MRI: is dynamic contrast-enhanced imaging necessary in addition to diffusion-weighted imaging? Diagn Interv Radiol 17 2011 243 248
33. C.K. Kuhl, P. Mielcareck, S. Klaschik, and et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211 1999 101 110
34. J. Ren, Y. Huan, H. Wang, and et al. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis Clin Radiol 63 2008 153 159
35. B.G. Hansford, Y. Peng, Y. Jiang, and et al. Dynamic contrast-enhanced MR imaging curve-type analysis: is it helpful in the differentiation of prostate cancer from healthy peripheral zone? Radiology 275 2015 448 457
36. M.A. Haider, P. Chung, J. Sweet, and et al. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy Int J Radiat Oncol Biol Phys 70 2008 425 430
37. T. Barrett, S.R. Davidson, B.C. Wilson, and et al. Dynamic contrast enhanced MRI as a predictor of vascular-targeted photodynamic focal ablation therapy outcome in prostate cancer post-failed external beam radiation therapy Can Urol Assoc J 8 2014 E708 E714
38. O. Rouvière, N. Girouin, L. Glas, and et al. Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI Eur Radiol 20 2010 48 55
39. E.M. Lawrence, F.A. Gallagher, T. Barrett, and et al. Preoperative 3-T diffusion-weighted MRI for the qualitative and quantitative assessment of extracapsular extension in patients with intermediate- or high-risk prostate cancer AJR Am J Roentgenol 203 2014 W280 W286
40. L. Vlatkovic, A. Svindland, H.B. Eggesbø, and et al. Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer J Urol 193 2015 466 472
41. M. Ohori, P.T. Scardino, S.L. Lapin, and et al. The mechanisms and prognostic significance of seminal vesicle involvement by prostate cancer Am J Surg Pathol 17 1993 1252 1261
42. M. Roethke, S. Kaufmann, M. Kniess, and et al. Seminal vesicle invasion: accuracy and analysis of infiltration patterns with high-spatial resolution T2-weighted sequences on endorectal magnetic resonance imaging Urol Int 92 2014 294 299
43. D.M. Berney, T.M. Wheeler, D.J. Grignon, et al. ISUP Prostate Cancer Group International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes Mod Pathol 24 2011 39 47
44. G.M. Glazer, M.B. Orringer, T.L. Chenevert, and et al. Mediastinal lymph nodes: relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging Radiology 168 1988 429 431
45. A. Qayyum Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications RadioGraphics 29 2009 1797 1810
46. C.E. Kahn Jr., C.P. Langlotz, E.S. Burnside, and et al. Toward best practices in radiology reporting Radiology 252 2009 852 856
47. L. Dickinson, H.U. Ahmed, C. Allen, and et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European Consensus Meeting Eur Urol 59 2011 477 494
48. A. Villers, L. Lemaitre, J. Haffner, and et al. Current status of MRI for the diagnosis, staging and prognosis of prostate cancer: implications for focal therapy and active surveillance Curr Opin Urol 19 2009 274 282
49. J. Haffner, L. Lemaitre, P. Puech, and et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection BJU Int 108 2011 E171 E178
50. J. Barentsz, A. Villers, and M. Schouten ESUR prostate MR guidelines. Author reply Eur Radiol 23 2013 2322 2323